Marijuana Analysis
Aurora Cannabis Q3 2019 Earnings Review – Holding Pattern Continues
Aurora (TSX: ACB) reported Q3 earnings and showed growth in revenue, gross profit while decreasing costs. However, concerns remain with…
A Guide to Cannabis Extraction – Sweet Spot or Bubble?
A comprehensive investor's guide to cannabis extractors - Valens Grow Works (VGW), MediPharm Labs (LABS), Neptune Wellness (NEPT) and Radient…
Aphria Q3 2019 Earnings Review – Headlines Create Opportunity
Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.
Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want
Organigram (CVE: OGI) posted another strong quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.
Canadian Cannabis Scorecard (Spring 2019)
Confused about which marijuana stocks are worth your money? The Canadian Cannabis Scorecard is your guide to separating the best…
Cronos Q4 2018 Earnings Review – The New Most Expensive Stock in Cannabis
In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with…
Tilray Q4 2018 Earnings – Eye Watering Stock Price Hard to Justify
Bottom Line This is likely a quarter Tilray's management wants to forget. Revenue of C$20.9 million missed even the low…
HEXO Q2 2019 Earnings – On the Edge of Profitability
A full review of HEXO (TSE: HEXO) Q2 2019 earnings. Should you buy this value priced name or are there…
Acreage Holdings Q4 2018 Earnings – Ignore the Loss, Focus on the Opportunity
Acreage Holdings Q4 2018 earnings show huge non-cash loss but leading footprint and discounted valuation keep us interested.
Edibles are Coming to Canada, but will Regulations Doom the Market?
The Opportunity The Canadian cannabis industry is looking forward to the legalization of edibles, extracts, and topicals. A change in…